[Angiogenin-induced angiogenesis as a target in the therapy of tumors].
Komolova
G S
GS
Bach Institute of Biochemistry, Russian Academy of Medical Sciences, Moscow, Russia.
Rustam'ian
Iu L
IuL
D043925:Angiogenesis Inducing Agents / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D006801:Humans; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D009369:Neoplasms / Q000098:blood supply* / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000098:blood supply* / Q000628:therapy*; D009389:Neovascularization, Pathologic / Q000209:etiology / Q000517:prevention & control*; D011506:Proteins / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000378:metabolism; D012259:Ribonuclease, Pancreatic / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D013329:Structure-Activity Relationship
D043925:Angiogenesis Inducing Agents; D000911:Antibodies, Monoclonal; D009363:Neoplasm Proteins; D011506:Proteins; D011956:Receptors, Cell Surface; C105154:angiogenin receptor; C046366:angiogenin; D012259:Ribonuclease, Pancreatic
Angiogenin-indutsiruemyĭ angiogenez kak mishen' v terapii opukholeĭ.